Recurrent adult immunoblastic large cell lymphoma Clinical Trials

Delta Trials records 81 clinical trials for Recurrent adult immunoblastic large cell lymphoma in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 62 trials have reached completion. This research is conducted across 62 study locations around the world. An additional 19 trials are active but not currently open for enrollment. Since 2020, 17 trials have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.